CASI PHARMACEUTICALS, INC. Accounts Receivable
CASI PHARMACEUTICALS, INC. had Accounts Receivable of $12.97 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-04-26
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $12.97M.
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $12.56M.
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $10.26M.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $10.09M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2022-12-31 | $12.97M 20-F · filed 2023-04-26 |
| 2022-09-30 | $12.56M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $10.26M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $10.09M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $9.80M 20-F · filed 2023-04-26 |
| 2021-09-30 | $5.42M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $5.77M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.84M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $4.64M 10-K · filed 2022-03-28 |
| 2020-09-30 | $4.08M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.60M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.87M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.29M 10-K · filed 2021-03-30 |
| 2019-09-30 | $2.64M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-28 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 |
| 2015-06-30 | $23.99K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $23.72K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $23.73K 10-K · filed 2016-03-28 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-27 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 |
| 2012-12-31 | $669.31K 10-K · filed 2014-03-21 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-14 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 |
| 2011-12-31 | $1.93M 10-K · filed 2013-03-21 |
| 2010-12-31 | $2.75M 10-K · filed 2012-03-09 |